Ann: Kazia appoints Karen Krumeich as CFO, page-21

First 21 Last

Share
Profile

Follow
rikki

2,795 Posts.

1723

13/12/21

18:31

Post #: 58263987
Share

Originally posted by davidfitz: ↑

Can’t verify that all of the following was attributable to just Karen but I am hopeful she was instrumental in some of these achievements with her previous employer.

Soligenix Appoints Karen Krumeich, asChief Financial Officer
Published:Jun 20, 2016

PRINCETON,N.J., June 20, 2016 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it has appointed Karen Krumeich, as its Senior Vice President and Chief Financial Officer. Ms. Krumeich has over 25 years of diverse experience in the financial and strategic management of emerging growth life science companies. She has a proven track record and expertise in corporate financial operations, equity financings, and business development, including partnerships, mergers and acquisitions.

ACHIEVEMENTS (after appointment)

Sep 12, 2016 - Soligenix andSciClone Establish Regional Licensing Agreement for SGX942, a Novel ProductCandidate for Oral Mucositis

Oct 25, 2016 - SoligenixReceives European Medicines Agency Designation as Small and Medium Enterprise

Dec 20, 2016 - SoligenixAdvances Collaboration with IDT Biologika

Jan 3, 2017 - SoligenixAnnounces Extension of Development Agreement with Emergent BioSolutions

Sep 13, 2018 - NIH selectsSoligenix’s SGX942 in the Treatment of Oral Mucositis for the CommercializationAccelerator Program

Expand

business development, including partnerships, mergers and acquisitions.

Hmmmmmmm…

KZA Price at posting: $1.13 Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

BUX

Buxton projects new graphite province discovery at WA Narryer play

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

There are more pages in this discussion • 5 more messages in this thread...

First 21 Last

Add KZA (ASX) to my watchlist

Ann: Kazia appoints Karen Krumeich as CFO, page-21

Top Stories

Buxton projects new graphite province discovery at WA Narryer play

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BCI reaches close of funding facility for salt-first part of Mardie project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Featured News